TCL Archive In Brief: “…In Case Mrs. Lasker Happens To See A Senator”; White Potter Defend Center Progress June 16, 1978
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive In Brief: White House Appoints Six to NCAB; Calabrisi To Succeed Korn As Chairman; 2 Spaces Vacant January 25, 1991
